Selected Recipients for this Program

Fiscal Year 2016: Fiscal Year 2016: objectives have been met. Support continued for the 61 tuberculosis (TB) and laboratory cooperative agreements with continued special emphasis on the completion of treatment, contact investigation, and targeted testing of high-risk populations. In addition, funding continued for six awards to support cross-cutting and disease-specific activities, including the prevention and control of HIV, viral hepatitis, STDs, and TB through prevention programs, capacity building for laboratory services, surveillance, human resources and organizational development, and monitoring and evaluation in the US Pacific Islands. Funding was also awarded to expand latent TB investigation testing and treatment to persons within a defined high-risk community in partnership with State and local health departments, community medical providers, and community leader and organizations. Fiscal Year 2017: It is estimated that support will continue as provided in fiscal year 2016. Fiscal Year 2018: It is estimated that support will continue as provided in fiscal year 2017.

Uses and Use Restrictions

Project funds may be used to support both local personnel and individuals in direct assistance (i.e., 'in lieu of cash') positions under Section 317 of the Public Health Service Act and to purchase equipment, supplies and services directly related to project activities, particularly directly observed therapy, patient outreach, morbidity surveillance, outreach and program assessment.

Project funds may not be used to supplant State or local funds available for tuberculosis control, or to support construction costs or inpatient care.

Eligibility Requirements

Applicant Eligibility

Under Section 317 of the Public Health Service Act, official public health agencies or their bona fide agents of State and local governments, including the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, Guam, the Northern Mariana Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, the Republic of Palau, and American Samoa.

Beneficiary Eligibility

Official public health agencies of State and local governments, including the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, Guam, the Northern Mariana Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, the Republic of Palau, and American Samoa.

Credentials/Documentation

Applicants should document the need for assistance, state the objectives of the project, outline the method of operations, describe the evaluation procedures, and provide a budget with justification of funds requested. 2 CFR 200, Subpart E - Cost Principles applies to this program.

Aplication and Award Process

Preapplication Coordination

Preapplication coordination is not applicable.

Environmental impact information is not required for this program.

This program is eligible for coverage under E.O.

12372, 'Intergovernmental Review of Federal Programs.' An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review.

Application Procedures

This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. Applicants must download application forms from www.Grants.gov. Applications must be submitted electronically at www.Grants.gov. If an applicant does not have access to the Internet, or if they have difficulty accessing the forms on-line, contact the CDC Office Grants Services Technical Information Management Section (OGSTIMS) staff. For this, or further assistance, contact OGSTIMS: Telephone (770) 488-2700, Email: OGSTIMS@cdc.gov. This program is subject to the requirements described in 45 CFR 92.

Award Procedures

This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. The standard application forms as furnished by PHS and required by 45 CFR, Parts 92, must be used for this program. Forms and instructions are available on www.grants.gov.

Deadlines

Contact the headquarters or regional office, as appropriate, for application deadlines.

Authorization

Public Health Service Act, Section 317(a)317E, 42 U.S.C. 247b-b(a), as amended; Health Services and Centers Amendments of 1978, Public Law 95-626; Omnibus Budget Reconciliation Act of 1981, as amended, Public Law 97-35; Preventive Health Amendments of 1984, Public Law 98-555; Public Health Service Act of 1987, as amended, Public Law 100-177; TB Prevention Amendments Act of 1990, as amended, Public Law 101-368.

Range of Approval/Disapproval Time

From 90 to 120 days.

Appeals

From 120 to 180 days.

Renewals

From 60 to 90 days. Information on the submission of applications may be obtained from the Grants Management Officer, Office of Grants Services, Centers for Disease Control and Prevention. The standard application forms, as furnished by PHS and required by 45 CFR 92 for State and local governments, must be used for this program. This program is subject to the requirements described in 45 CFR 92.

Assistance Considerations

Formula and Matching Requirements

This program has no statutory formula. This program has no matching requirements. This program has no statutory formula or matching requirements. Although there are no matching requirements, applicants must assume part of the project costs and fiscal information must be provided in the narrative portion of the application pursuant to provisions of Section 317(b)(2)317E. MOE requirements are not applicable to this program.

Length and Time Phasing of Assistance

Project Period: From one to five years. Budget Period: One year. Method of awarding/releasing assistance: lump sum.

Post Assistance Requirements

Reports

See notice of funding opportunity (NOFO) for details.

CDC programs must require awardees to submit performance measure annually as a minimum, and may require reporting more frequently.

Performance measure reporting must be limited to data collection.

When funding is awarded initially, CDC programs must specify required frequency, data fields, and format.

No cash reports are required.

The Annual Performance Report is due no later than 120 days prior to the end of the budget period.

The Annual Performance Report serves as the continuing application.

This report should include the information specified in the notice of funding opportunity (NOFO).

The Annual Federal Financial Report is required 90 days after the end of each budget period.

Final Financial Reports are required 90 days after the end of a project period.

Annual financial status reports are also required of the recipient no later than 90 days after the end of each budget period.

Final financial status and are required 90 days after the end of a project period.

See NOFO for details.

Awardees will meet the annual requirement to report on performance measures with the submission of an Annual Performance Report.

However, CDC may request an additional report, the Performance Measure Report, in certain instances such as a jurisdiction?s response to a large TB outbreak.

Audits

In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503. In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal officials.

Records

Financial records, supporting documents, statistical records, and all other records pertinent to the project shall be retained for a minimum of 3 years, or until completion and resolution of any audit in process or pending resolution. In all cases, records must be retained until resolution of any audit questions. Property records must be retained in accordance with PHS Grants Policy Statement requirements.

Financial Information

Account Identification

75-0950-0-1-550.

Obigations

(Cooperative Agreements) FY 16 $80,863,811; FY 17 est $79,830,700; and FY 18 est $79,830,700 - It should be noted that for PS13-1304, RTMCCs, the funding in TAGGS is being reported under 93.116 when the NOFO itself shows 93.947. OGS corrected the NOAs by doing deobligation/reobligation for FY13 and FY14; however for FY15 funding is showing under 93.116.

Range and Average of Financial Assistance

$86,938 to $9,9,317,764 with an average of $1,454,714.

Regulations, Guidelines, and Literature

Subpart A of 42 CFR 51b is applicable, including all regulations incorporated by reference under Section 51b.105. PHS Grants Policy Statement, DHHS Publication No. (OASH) 94-50,000, (Rev.) April 1, 1994, is available.

Information Contacts

Regional or Local Office

None.

Headquarters Office

Terry Chorba 1600 Clifton Road, MS E-10, Atlanta, Georgia 30333 Email: tlc2@cdc.gov Phone: 404-639-0909 Fax: 404-639-8958

Criteria for Selecting Proposals

All applications will be reviewed initially for completeness by CDC. Incomplete applications that do not meet the eligibility criteria will not advance. Applicants will be notified that their applications did not meet eligibility or published submission requirements. A review panel will evaluate complete, eligible applications in accordance with the ?Criteria? section of the notice of funding opportunity (NOFO).